Five new drafts published [BE/BA News]
Dear all,
on 01 August the EMA published a new batch of product specific guidances for comment:
on 01 August the EMA published a new batch of product specific guidances for comment:
- Abiraterone tablets 250 mg.
- Exenatide powder and solvent for prolonged-release suspension for injection, 2 mg, and powder and solvent for prolonged-release suspension for injection in pre-filled pen, 2 mg.
- Paliperidone palmitate depot suspension for injection 25, 50, 75, 100 and 150 mg.
- Vandetanib film-coated tablets 100 and 300 mg.
- Vemurafenib fim-coated tablets 240 mg.
—
Dif-tor heh smusma 🖖🏼 Довге життя Україна!![[image]](https://static.bebac.at/pics/Blue_and_yellow_ribbon_UA.png)
Helmut Schütz
![[image]](https://static.bebac.at/img/CC by.png)
The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes
Dif-tor heh smusma 🖖🏼 Довге життя Україна!
![[image]](https://static.bebac.at/pics/Blue_and_yellow_ribbon_UA.png)
Helmut Schütz
![[image]](https://static.bebac.at/img/CC by.png)
The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes
Complete thread:
- EMA: 7 product-specific guidances adopted Helmut 2015-07-07 14:10 [BE/BA News]
- EMA: 7 product-specific guidances adopted mittyri 2015-07-08 13:55
- capecitabine ≠ NTID; reference-scaling Helmut 2015-07-08 14:59
- Tadalafil: Similar technology and formulas as the originator luvblooms 2015-07-10 07:24
- Tadalafil: Similar technology and formulas as the originator mmw 2015-07-17 11:38
- 9 new just published Ohlbe 2016-04-07 19:08
- Five new drafts publishedHelmut 2016-08-23 15:09
- New product specific guidance of Fidaxomicin Mahesh M 2016-08-24 05:58
- EMA: 7 product-specific guidances adopted (Capecitabine) Mauricio Sampaio 2016-12-12 19:33
- Capecitabine: study with healthy volunteers mittyri 2016-12-14 12:39
- EMA: 7 product-specific guidances adopted mittyri 2015-07-08 13:55